R. Kent Jr. McGaughy - 07 Jun 2023 Form 4 Insider Report for REATA PHARMACEUTICALS INC

Role
Director, 10%+ Owner
Signature
/s/ R. Kent McGaughy, Jr.
Issuer symbol
N/A
Transactions as of
07 Jun 2023
Net transactions value
+$119,951
Form type
4
Filing time
09 Jun 2023, 16:30:38 UTC
Previous filing
04 Apr 2023
Next filing
10 Jan 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RETA Stock Option (right to buy) Award $119,951 +1,628 $73.68 1,628 07 Jun 2023 Class A common stock 1,628 $93.61 Direct F1, F2
transaction RETA Stock Option (right to buy) Award $0 +4,275 $0.000000 4,275 07 Jun 2023 Class A common stock 4,275 $93.61 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vest in 4 equal installments on September 7, 2023, December 7, 2023, March 7, 2024, and June 5, 2024, subject to continued service through each vesting date.
F2 This option was issued to the reporting person pursuant to the Reata Non-Employee Director Compensation Policy in lieu of future director fees of $119,954.